Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Preceptorship on Ovarian Cancer 2022: Lisbon

23 - 24 Sep 2022

Lisbon, Portugal

ESMO-Preceptorship-Ovarian-Cancer-1000x1000

Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning objectives

  • To learn about best clinical practice in the multidisciplinary management of early and late stage ovarian cancer
  • To understand the importance of biology and pathology of common and rare ovarian tumours
  • To understand the options for treatment of recurrent disease and how treatment-decisions are made
  • To understand the novel therapeutic agents being developed to treat ovarian cancer and how knowledge of genomics and molecular pathways guides drug development
  • To learn about the management of patients with symptoms of the disease and the side-effects of treatment

This event has been supported by an unrestricted educational grant from GSK.

Hide
Filter by:

There are 26 resources available

Welcome and Introduction

Presenter: S. Banerjee, UK and I. Ray-Coquard, FR

Session: Welcome and Introduction

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.